Literature DB >> 11050308

Tryptanthrin inhibits nitric oxide and prostaglandin E(2) synthesis by murine macrophages.

T Ishihara1, K Kohno, S Ushio, K Iwaki, M Ikeda, M Kurimoto.   

Abstract

Nitric oxide (NO) and prostaglandins have been implicated in the pathogenesis of several inflammatory diseases. In this study, we investigated the effect of tryptanthrin (6,12-dihydro-6, 12-dioxoindolo-(2,1-b)-quinazoline), an antimicrobial and antitumoral plant compound isolated from Porigonum tinctorium, on NO and prostaglandin E(2) production by interferon-gamma and lipopolysaccharide-stimulated murine macrophage-like RAW 264.7 cells. Tryptanthrin markedly inhibited both NO and prostaglandin E(2) production in a dose-dependent manner. Tryptanthrin at 20 microM fully inhibited expression of inducible NO synthase, suggesting that the inhibitory effect on NO synthesis was mediated by inhibited expression of the enzyme. On the other hand, tryptanthrin had no effect on the levels of cyclooxygenase-2 protein, but inhibited cyclooxygenase enzyme activity with a ICM(50) value of 1.5 microM. Thus, tryptanthrin has the dual functions of inhibiting both NO and prostaglandin E(2) production by activated macrophages, suggesting that tryptanthrin exhibits anti-inflammatory properties.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050308     DOI: 10.1016/s0014-2999(00)00674-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  22 in total

1.  Kourokhitin, a potential drug containing two active substances.

Authors:  A M Popov; Yu M Gafurov; T V Moskovkina; A V Kachanov; O N Krivoshapko; S E Petrovicheva; V A Stonik
Journal:  Dokl Biochem Biophys       Date:  2009 May-Jun       Impact factor: 0.788

2.  Low-dose action of tryptanthrin and its derivatives against developing embryos of the sea urchin Strongylocentrotus intermedius.

Authors:  Irina G Agafonova; Taisiya V Moskovkina
Journal:  Environ Monit Assess       Date:  2018-08-07       Impact factor: 2.513

Review 3.  Biologically active quinoline and quinazoline alkaloids part II.

Authors:  Xiao-Fei Shang; Susan L Morris-Natschke; Guan-Zhou Yang; Ying-Qian Liu; Xiao Guo; Xiao-Shan Xu; Masuo Goto; Jun-Cai Li; Ji-Yu Zhang; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2018-02-27       Impact factor: 12.944

4.  On the inhibition of 5-lipoxygenase product formation by tryptanthrin: mechanistic studies and efficacy in vivo.

Authors:  C Pergola; B Jazzar; A Rossi; H Northoff; M Hamburger; L Sautebin; O Werz
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 5.  The Malassezia genus in skin and systemic diseases.

Authors:  Georgios Gaitanis; Prokopios Magiatis; Markus Hantschke; Ioannis D Bassukas; Aristea Velegraki
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

6.  The lipopolysaccharide-induced pro-inflammatory response in RAW264.7 cells is attenuated by an unsaturated fatty acid-bovine serum albumin complex and enhanced by a saturated fatty acid-bovine serum albumin complex.

Authors:  Chi Fen Chang; Yat Pang Chau; Hsiu Ni Kung; Kuo Shyan Lu
Journal:  Inflamm Res       Date:  2011-11-18       Impact factor: 4.575

7.  Cytotoxicity and reversal of multidrug resistance by tryptanthrin-derived indoloquinazolines.

Authors:  Sung-tsai Yu; Ji-wang Chern; Tzer-ming Chen; Yi-fan Chiu; Hui-ting Chen; Yen-hui Chen
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

8.  Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Andrei S Potapov; Anastasia R Kovrizhina; Vladislava V Matveevskaya; Maxim L Belyanin; Dmitriy N Atochin; Svitlana O Zanoza; Nadiya M Gaidarzhy; Sergiy A Lyakhov; Liliya N Kirpotina; Mark T Quinn
Journal:  Eur J Med Chem       Date:  2018-10-12       Impact factor: 6.514

9.  Proliferation-attenuating and apoptosis-inducing effects of tryptanthrin on human chronic myeloid leukemia K562 cell line in vitro.

Authors:  Shan Miao; Xiaopeng Shi; Hai Zhang; Siwang Wang; Jiyuan Sun; Wei Hua; Qing Miao; Yong Zhao; Caiqin Zhang
Journal:  Int J Mol Sci       Date:  2011-06-10       Impact factor: 5.923

Review 10.  Oxidative Stress as a Possible Target in the Treatment of Toxoplasmosis: Perspectives and Ambiguities.

Authors:  Karolina Szewczyk-Golec; Marta Pawłowska; Roland Wesołowski; Marcin Wróblewski; Celestyna Mila-Kierzenkowska
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.